The Science Journal of the Lander
College of Arts and Sciences
Volume 9
Number 1 Fall 2015
1-1-2015

What Are the Possible Causes for Autism Spectrum Disorder?
Rochel Preiserowicz
Touro College

Follow this and additional works at: https://touroscholar.touro.edu/sjlcas
Part of the Developmental Biology Commons, and the Developmental Psychology Commons

Recommended Citation
Preiserowicz, R. (2015). What Are the Possible Causes for Autism Spectrum Disorder?. The Science
Journal of the Lander College of Arts and Sciences, 9(1). Retrieved from https://touroscholar.touro.edu/
sjlcas/vol9/iss1/15

This Article is brought to you for free and open access by the Lander College of Arts and Sciences at Touro Scholar.
It has been accepted for inclusion in The Science Journal of the Lander College of Arts and Sciences by an
authorized editor of Touro Scholar. For more information, please contact touro.scholar@touro.edu.

-
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Rochel Preiserowicz graduated in June 2015 with a B.S. degree in Biology and is now in the Doctor of Pharmacy program at L.I.U.

Abstract
Ever since the mid 1980’s when Autism Spectrum Disorder (ASD) started to become increasingly prevalent, researchers
have been trying to find a possible cause for it. Autism Spectrum Disorder is a developmental disorder that manifests
itself in children who are between 18-30 months old. People with autism have reduced social skills, and they have a
difficult time communicating verbally and non-verbally. Autism is diagnosed through a questionnaire and other instruments that allow psychologists, psychiatrists, speech therapists, neurologists and many other doctors to determine if a
child has a form of ASD. There are many theories about what causes autism. It has been widely believed that vaccines,
specifically the MMR vaccine causes autism, but that theory has been disproven. Another possibility is the role genetics
plays in ASD. Many studies have been done to determine which genes might cause autism. Because of the heterogeneity
of the symptoms and behaviors of people with autism and general genetic complexity it has been hard to find a specific
genetic cause of autism.While a confirmed gene has not been determined to cause autism many studies have been done,
some using whole-exome sequencing (WES) to see if mutations in parent’s genes caused their children to have autism.
It is also possible that autism can be caused by hereditary or parental factors. There have also been theories that
environmental factors play a role in autism such as exposure to tobacco, pollutants, and metals, and including maternal
conditions that could affect the fetus. While many of the studies were inconclusive, and a confirmed cause of autism
has not been found, the studies do show that genetics does play a major role in ASD, though more studies will have to
be done to determine how and which genes cause it.
Introduction
Autism Spectrum Disorder (ASD) is a neurological impairment
where the child has a problem interacting with others, has trouble communicating verbally and non-verbally, and exhibits odd
behaviors such as repeating certain actions over and over again
and acting out if something does not go according to routine
(Block et. al., 2006). A child with ASD will have trouble making
eye contact with those interacting with him and will be unable
to understand what others are thinking or feeling because they
have trouble picking up on social cues (“What is Autism”, 2009)
ASD is predicted to occur in three to six children for every
1000 who are born. It is 5 times more likely for a male to get
autism than a female, however if a female does have autism her
symptoms are more severe. Autism Spectrum Disorder is categorized as a pervasive developmental disorder because there
are many different symptoms and behaviors for people with
autism. Someone who has severe symptoms of autism can be
placed on one end of the spectrum, while someone with a milder case can be on the opposite end of the spectrum. Different
forms of ASD include Rett’s disorder, childhood disintegrative
disorder, and Asperger’s syndrome. (Block et. al., 2006).

Methods
The information that was collected for this research paper was
obtained through Proquest, Ebsco, Pubmed, and the NIH website. These resources were provided from the Touro College
Library. Key words included autism, ASD, vaccinations, genetics,
and environmental factors.

Discussion: Diagnosing Autism
There is no specific test done to determine if a child has ASD
because the symptoms and behaviors are so broad and can vary

significantly between each child. Although children can start
showing symptoms between 15-18 months of age, the average age of diagnosing is four to five years old. Diagnosis for
ASD should be done by gathering developmental history of
the child, and by direct observation of the behaviors of the
child. There should be a team of different professionals who
can assess symptoms and behaviors of the child. The team
should include a pediatrician, a child psychiatrist, and a speech
and language therapist, and a child psychologist. Behavior of
the child should be observed in different settings such as in
his home and in his school. The team should be looking for
different behaviors that are prevalent in children with ASD.
Prognosis of each case is done on an individual basis because
the behaviors of the child can vary greatly, and the behaviors
can even change over time. Some people with autism can lead
productive lives, such as those with high functioning Asperger’s
syndrome, while others will need assistance all through their
lives (Yates et. al., 2013).

MMR Vaccine and Autism
There has been much talk over the years about a possible
link between the Mumps, Measles and Rubella (MMR) vaccine
and autism. The supposed link caused major panic because
vaccines are needed to prevent, in this case, mumps measles
and rubella from spreading. Vaccines were a vital discovery
which prevented many infectious diseases from recurring over
and over again around the world.
The link between the vaccine and autism was introduced by
Andrew Wakefield in 1998 (cited in Richards, 2011), when
he conducted an experiment using twelve children to prove
the link. It came out later, while his experiment was under
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investigation, that he altered many of the details of the children’s previous symptoms and behaviors. Therefore his study
had no scientific basis to prove a link. Many studies have been
done since then to disprove the supposed link between the
MMR vaccine and autism (Richards, 2011).
One reason why people may think there is a link between
the MMR vaccine and ASD is because children start showing signs of autism right around the time that they get the
vaccine. The explanation for this is that the vaccine is given
to children only after they are a year old, which is when
children start showing symptoms and unusual behavior. Just
because these events happen around the same time does not
mean that there is any basis for a connection. Many studies
were done to try to prove a link between the vaccine and
autism but none of them have been successful (‘Autism and
the MMR Vaccine’, 2001).

Investigations done to disprove the link
In 2000, the Institute of Medicine at the National Academy of
Science, under the request of the CDC and NIH conducted
a review of all the evidence linking the MMR vaccine to ASD.
They took under consideration all the studies and concluded that the evidence did not support an association between
the vaccine and autism. Furthermore in 2000, the American
Academy of Pediatrics held a conference to review the information and found no evidence in support of a linkage (‘Autism
and the MMR Vaccine’, 2001).
In 1999, Taylor and colleagues published a study to determine
a connection between the MMR vaccine and autism (‘Autism
and the MMR Vaccine’, 2001). He took all the known cases of
ASD in children living in certain districts in London who were
born in 1979 or later and matched the ASD patients with an
independent registry of vaccinations. His results were: 1. the
number of ASD cases had increased steadily since 1979 but
there was no steep incline in cases after doctors started using
the MMR vaccine. 2. Children showed symptoms and were
diagnosed with ASD all at around the same age, regardless if
they got the vaccine before or after 18 months of age. This
is important because if the children were vaccinated they
would have shown signs of ASD earlier than those children
who were not vaccinated. 3. Lastly, by age two the number
of children who got the vaccine and showed signs for ASD
was almost the same amount as children who got the vaccine
but did not show any symptoms. If there was a connection
between the MMR vaccine and autism more children should
have shown symptoms for ASD (NICHD, 2001). Although the
MMR vaccine was a popular theory concerning the causes of
autism, many later studies failed to show a connection. This
still remains controversial and continues to be studied.
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Genetic factors that may cause ASD
possible genetic mutations that cause autism
Another possible cause of autism is genetic mutations in the
genome of the affected person. Mutations in genes that are
responsible for encoding proteins which are involved in molecular machinery regulating synaptic protein synthesis is strongly
connected to autism. Autism possibly can be caused due to
mutations known as Fragile X Syndrome and tuberous sclerosis
(TS). Both of these syndromes are caused by abnormal mRNA
translation, resulting in excess protein synthesis.
Fragile X Syndrome (FXS) is caused by an unstable expansion of
the CGG repeat in the FMR1 gene. The prevalence of autism in
the FXS mutation is 30%. This gene mutation causes abnormal
methylation production, FMR1 transcription silencing, and decreased FMRP protein levels in the brain. ASD in FXS is mainly
characterized by deficits in peer interaction. Tuberous sclerosis
is an autosomal dominant disease that is caused by a mutation on
either the TSC1 or TSC2 gene. Clinical manifestations of tuberous
sclerosis included epilepsy, learning difficulties, and behavioral problems. There are a variety of mutations that cause tuberous sclerosis including nonsense, missense, insertion, and deletion mutations.
Autism is significantly more frequent among TS patients than in the
general population. Because there is a large phenotypic variability
in FXS and TS with patients who have autism, research is being
done to make a clear correlation (Perisco et. al., 2013).

Using Whole-Exome Sequencing (WES) to
determine possible genetic links to ASD
Whole-Exome Sequencing (WES) is a technique which captures
and sequences the exons in the genome to reveal all de novo
and low frequenting alleles that contribute to genetic risk for disease. This method is cheaper than Whole-Genome Sequencing,
because instead of searching through the entire genome, it only
goes through the exons in the genome, which only takes up 2-3%
of the genome. This technique is better than the previously used
technique of Genome Wide Association Studies (GWAS) because GWAS only reveals risk factors that are common in the
population (Icahn School of Medicine, 2012). WES is particularly
good for finding the cause of ASD because ASD can be caused
from different genes in many different locations with a weak genotype and phenotype correlation (Perisco et. al., 2013).
A study was done applying WES on families where the spouses
were related and on families where cousins shared the same
disease. This way it is easier to identify specific mutations that
cause ASD. The mutations that were identified on the genes
were hypomorphic mutations, meaning that the altered gene
product has a reduced level of activity, which can explain the
wide spectrum of ASD. This analysis was done on three families.
In this paper the first family will be discussed.

Causes for Autism Spectrum Disorder

The first family had three children with ASD and two unaffected
children. The parents were first cousins. WES was performed
and it showed a single linkage peak in a large homozygous interval, and suggested a 900:1 likelihood that the responsible mutation was found in this homozygous interval. Then WES was
performed on one of the affected children. The linked interval
showed only a single rare change that was absent in the known
databases and population matched controls.

patients with ASD show significant reductions in the temporal
lobe blood flow. The study was done in fuller depth where an
fMRI (functional MRI) was done on adults with ASD that showed
significantly less amygdala activation during a mentalizing task
called “Judging the Mind in the Eye” task. In this experiment, six
people with autism were matched for mean age, handedness, IQ,
socioeconomic status and educational level with twelve people
in the normal group.

This mutation was on a gene that is responsible for the production of the enzyme AMT, aminomethyltransferase. This enzyme
is needed for the breakdown of glycine. Sanger Validation confirmed that the mutation was heterozygous in both parents, homozygous in the affected children, and absent or heterozygous in
the unaffected children.

In the fMRI scanner a blocked periodic ABA design was used.
There were two tasks. The first task, Task A, was supposed to
induce periodic MR signal changes, with signal maximum in brain
regions relatively specialized from gender recognition from facial stimuli. In this task, the subjects were visually presented
with pictures of eyes and were asked to indicate by right button
pressing if the picture was a male or female.

Mutations in AMT cause nonketotic hyperglycemia (NKH), which
is a neonatal syndrome that causes lethargy, hypotonia, several
seizures and death within the first year. Rarer, atypical forms of
NKH have been described in association with hypomorphic missense AMT mutations. This manifests at a later age and causes
delay in expressive language, behavioral problems and seizures.
While individually non diagnostic, when all three children were
tested they exhibited a range of neurological symptoms that
were strongly suggestive of NKH (Yu et. al., 2013).

The amygdala theory of autism
There is a network of neural regions that comprise the “social
brain”: the orbit-frontal cortex, the superior frontal sulcus, and
the amygdala. This region of the brain is responsible for social
intelligence, a quality which ASD patients are known to be lacking. The Neuroscience and Behavioral Reviews has come up
with The Amygdala Theory of Autism, where they hypothesize
that patients with ASD have an amygdala deficit which causes
the deficit in social skills.
An experiment was done on rhesus monkeys which showed
that ibotenic acid lesions of the amygdala affect the social behavior of the monkeys and they also became socially isolated.
When the amygdala-lesioned monkeys were sent into the wild,
they were unresponsive to group members, failed to display appropriate social signals and they withdrew from other animals.
When another study was done, where lesions were made to the
monkeys’ anterior temporal lobe, which included the amygdala,
the monkeys showed specific symptoms, for example they had a
tendency to overreact to all objects, they were hyperemotional,
they had a loss of fear, and they started to investigate objects
with their mouth instead of their hands.
Then a study conducted with humans was done. They used
single photon emission computed tomography that showed that

The second task, Task B, was checking the periodic MR signal
change with signal maximum in brain regions relatively specialized in mental state recognition from facial stimuli. In this task, a
response involved choosing between two words that described
the mental state of the photographed person.
The key difference between the two tasks was seeing the subject’s judgement between the two pictures. Social intelligence is
about picking up social cues, such as the expression of people’s
faces to understand what the person is thinking.
The subjects who had ASD had a hard time doing task B. The
fMRI data was analyzed in two stages. First, generic brain activation maps were constructed separately for the control
and autistic groups. By doing so, they were able to determine
which voxels were activated in each group by each of the two
tasks. Secondly, ANOVA was used to determine the voxels that
demonstrated a significant difference between groups in mean
power of response to each task.
The autistic group activated the frontal components less extensively than the control group, and they did not activate the
amygdala at all. The control group demonstrated significantly
greater power of response in their bilateral superior temporal
gyrus. The autistic group seems not to use the amygdala for the
task, and compensated by using a greater processing load on
temporal lobe structures, which specializes in verbally labeling
complex visual stimuli. This may be because of compensation
for an amygdala abnormality (Baron-Cohen et. al., 2000).

Maternal diabetes and autism
A study was done to investigate if Gestational Diabetes Mellitus
(GDM) in the mother may result in the child having ASD.
Specifically, researchers were determining if the timing of when
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the mother developed GDM had any significance whether the
child would develop ASD.
This study included children who were born at 28-44 weeks
gestation. Women who had type 1 diabetes and congenital
anomalies were excluded from the study. The primary variable
was maternal type 2 diabetes or maternal GDM during pregnancy. Exposures were broken up into three categories- 1. No
exposure to maternal diabetes, 2. Exposure to maternal type 2
diabetes, and 3. Exposure to maternal GDM. Other variables
that were included were maternal age at delivery, education,
self-reported maternal race/ethnicity, and the gender of the
child. For the GDM exposed group, the different methods that
were used to diagnose were also recorded. The gestational
weeks were also split up into three categories- 1. Diagnosed
26 weeks or earlier, 2. Diagnosed after 26 weeks but before 30
weeks, 3. Diagnosed at 30 weeks or later.
The primary data analysis was collected from 322,323 children. The children were checked up on approximately five
and a half years after birth. During this time, 3,388 children
were diagnosed with ASD. A large amount of mothers who
got GDM during the first 26 weeks of pregnancy gave birth
to a child with ASD. It is also interesting to note that among
the children who had ASD, 121 of them had older siblings who
also had ASD.
To summarize, mothers with pre-existing type 2 diabetes were
not significantly associated with risk of ASD, but mothers who
got GDM earlier than 26 weeks of pregnancy were significantly
associated with risk of ASD (Xiang et. al., 2015).

De Novo Mutations
De novo mutation is an alteration of a gene that was present for
the first time in one family member as a result of a mutation in a
germ cell (egg or sperm) of one of the parents or in the fertilized
egg itself (Genetics Home Reference, 2015). De novo mutations
are important in finding the cause of ASD.
Studies show that the majority of de novo mutations do not
cause the disease, they only increase the risk of getting the disease. There may be several genes in which a high risk of de novo
mutations can occur from. Through these studies many de novo
mutations were found that predicted that these mutations would
disrupt the gene function in a child with ASD, however these mutation are not necessarily what causes the disease. Two studies
also found that de novo mutations are caused from the paternal
side and are age dependent. There is a detectable increase in autism risk with children who were born to older fathers (Perisco
et. al., 2013).

Advancing parental age and autism
There are a number of studies which are trying to determine if
the age at which the parents conceived the child increases the
risk of the child being born with ASD. Whole-Exome Sequencing
links older fathers to de novo mutations and increased risk of
having a child with ASD. The linkage of older mothers having a
child with ASD follows different pathways.
Prevalence of ASD has increased from 5 cases per 10,000 people in the 1980’s to the latest CDC’s estimate of 1 case in every
68 people. This may be due to a variety of reasons, including
changes in diagnostic practice, heightened awareness, or even
an actual increase in the disorder. One factor that might cause
ASD is parental age, since there is a tendency in recent years for
people to become parents later in life. In Spain and England the
proportion of mothers who had children after 35 years old in
1980 was 14% and 25% respectively. In 2007, the proportion of
mothers who had children after 35 years old increased to 25%
and 40% respectively.
There are more than forty studies being done trying to link age
of parents when they had kids to ASD. While individual studies
are not consistent with their findings, this can be because of a
number of factors. The discrepancies can be caused by inconsistent sample sizes and characteristics, or missing data. The
studies did conclude an increased risk of ASD from both older
parents, an older father but not older mother, and older mother
but not older father, and neither an old mother or old father.
Inconsistencies could have also been affected by the fact that
these studies did not take into account socioeconomic status
of the families or co-parental age.
The general consensus is that advancing paternal age (APA) and
advancing maternal age (AMA) are independent factors that can
increase the risk of having children with ASD.
In 2012 meta-analysis focused on advancing maternal age and a
link to autism, using data from over 25,000 ASD patients, and
eight million controls aggregated from 10 studies. The results
were that mothers who were 35 years or older when they had
the child had a 1.5 fold increased likelihood of having a child with
ASD compared to mothers who had children at 25-29 years of
age. In 2010, a study was done to test the theory of advancing
paternal age and its link to autism. Meta-analysis was done on
eleven studies and found that fathers who were 40-49 years old
when they had children, had a 1.8 fold increased likelihood of
having a child with ASD, compared to fathers who were 29 years
old or younger.

APA effects on ASD
At this point the question is how APA and AMA are associated
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with a child being born with ASD. One possibility of why age
affects ASD is age- related mutagenesis in the male germ cell.
While a female germ cell undergoes 22 mitotic cell divisions in
utero, male germ cells undergo 30 mitotic cell divisions in embryogenesis, and then divide every 16 days from puberty and on.
Because the male germ cell undergoes many more cell divisions
during his reproductive age, there is more of a possibility of gene
copying errors, which can lead to de novo mutations in the male’s
child, which can cause ASD.
Multiple studies that are using Whole-Exome or Genome
Sequencing found that higher numbers of de novo loss-offunction single nucleotide variants are seen in fathers of increasing age. While it is fine for a new born to have between
30-100 de novo point mutations, there is an increase of about
one to two mutations for each increasing year of a father’s
age. If the mother is also older, it increases the likelihood of
more de novo mutations, because AMA and APA can be linked
together.
Two studies were conducted to disentangle APA effects from
AMA effects on the child. The studies used multiple regression
which was adjusted so that both parental ages were entered
as predicators. It was found that APA remained a significant
predicator in de novo mutations while AMA effects were negligible. Two thousand, five hundred families who had one child
with ASD were analyzed and found that a majority of the de
novo mutations originated from the father. It should be pointed out that although de novo mutations can affect any biological system, there is reason to believe that de novo mutations
differentially impact brain development because the brain may
have fewer redundancy mechanisms that are needed to inhibit
mutations (Lee et. al., 2015).
They hypothesized that if mutations in germ cells result in a
slightly faster rate of cell division, then cells with these mutations will expand within the testes and logically they will
contribute to the larger proportion of sperm. This process is
known as “selfish spermatogonial selection”. This mechanism
can favor the propagation of germ cells which are carrying mutations that prefer to impact certain cellular signal pathways.
(Lee et. al., 2015).

AMA effects on ASD
One possible correlation between AMA and ASD would be
assisted reproductive technologies which are used by couples
more commonly with increasing age. A Swedish study was
done which involved 2.5 million infants. The results were that
in vitro fertilization procedures had no association with risk
of ASD, while a specific procedure called “Intracytoplasmic
Sperm Injection (ICSI)” has a slightly increased risk of having

children with ASD. ICSI is done when there is paternal infertility. The reason why ICSI can increase risk of ASD is because
the injection process can damage the egg which can increase
the risk of adverse outcomes.
Another possible correlation can be the fact that a person
accumulates more and more environmental toxins with increasing age. Environmental factors such as pesticides, heavy
metal, and organic pollutions have been linked with increased
risk of ASD. Human brain samples were examined and found
that exposure to polychlorinated biphenyl 95 strongly predicted maternal 15q11-q13 duplication, which is one of the most
common CNV findings in ASD cases (Lee et. al., 2015).

Other factors that effect advancing parental age
and autism
A study was done using 1,251 ASD cases occurring in over
250,000 births throughout the United States. This study found
a connection between parental age and birth order with increasing risk of ASD. Younger parents (mother younger than
35, father younger than 40), on their first birth, had a 1.7 fold
increased odds of having a child with ASD compared to other
young parents on their third birth and later. Regardless of the
age of the parents, the risk of ASD is increased in first born
children. Older parents (mother older than 35, father older
than 40) on their third child or later had a 1.8 fold increase
on the likelihood of having a child with ASD. Older parents on
their first child had a 3.1 fold increase on the odds of having a
child with ASD. To conclude, the effect of parental age on ASD
is amplified if it is their first birth (Lee et. al., 2015).

Environmental chemical exposures and autism
spectrum disorder
Autism can be caused by a mixture of genetic and environmental influences, and studies are being done to understand
the interplay of both contributions. These contributions can
be different from one person to the next. A study in Sweden
was done which included 14,000 children with autism. The
study showed that heritability contributed to 50% of a possible cause of autism while environmental factors contributed
an equally strong role. Genetic and environmental factors may
work together to disrupt the normal process of nervous system development, interfering with neuron formation and migration, synapse formation, or neurological connectivity which
can cause ASD.
In this study, the chemical exposures that were included are
ones that can be reduced in exposure, which opens up possibility for prevention of autism. Of course it can only be reduced
because not all exposure can be controlled, such as air pollution
and any toxic chemical that are unknown to the patients.
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Maternal smoking in pregnancy and ASD
diagnosis
Seven studies were included which were done in the United
States, Canada, Sweden, Norway, Finland, and England/Whales.
These studies showed no association between maternal smoking during pregnancy and ASD diagnosis. Some of the studies
focused on the spectrum of autism. There was an elevation in
two of the studies between maternal smoking during pregnancy and higher functioning autism, such as Asperger’s syndrome,
compared to lower functioning autism. Overall, there is no
conclusive evidence that maternal smoking or tobacco exposure to a fetus has any effect on a child being born with autism
(Kalkbrenner et. al., 2014).

Regulated and traffic related air pollutants
exposure and ASD
Air pollutants include hundreds of chemicals which can be
categorized into three categories: 1. Point pollutants arising
from spatially separated large buildings, for example factories
and power plants. 2. Area pollutants associated with population density, for example gas stations and dry cleaners. 3.
Mobile pollutants associated with vehicles. In this paper we
will be discussing the third category. When these pollutants
enter the atmosphere they undergo reactions that create new
pollutants. Specific chemicals that arise from traffic that will
be discussed here are particulate matter (PM), NO2; nitrogen
dioxide, and O3; ozone.
Air pollutants enter the body through inhalation and direct
transportation from the nose to the brain via the olfactory
bulb. Some chemical pollutants are known to induce oxidative stress and cause a systemic inflammatory reaction, which
can alter normal neurodevelopment. Fetuses itself can come
in contact with chemicals from air pollutants or they can be
exposed to them from the elevated levels of inflammatory cytokines in the maternal circulation.
Seven studies were done in the United States with adequate
sample sizes ranging from 284 to 7,594 children with autism.
The studies also had controls under consideration such as maternal age and the parent’s level of education. Season of birth
is also important to take under consideration because occurrence of autism varies by season of conception for unknown
reasons. It is also important because certain air pollutants
have a stronger concentration in some seasons over other
season, such as influenza infection and vitamin D levels.
Results for this study concluded that exposure to pollutants
such as PM2.5, PM10, and NO2, were associated with the risk
of getting autism. For almost every pollutant in every study, associations were stronger for exposures in the third trimester
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of pregnancy and the first year of life compared to earlier
on in the pregnancy. All of these studies estimated exposure
to outside levels of these air pollutants using historical data
that could be related geographically to the home residence
of the pregnant woman or infant, because retroactive direct
person-based air sampling was not possible (Kalkbrenner et
al 2014).

Metal (Ethylmercury) from vaccinations
and ASD
Connecting this discussion back to vaccinations, thimerosal
was thought to be a toxic compound that increased the risk
of autism. Thimerosal is a vaccine preservative that contains
ethylmercury which is considered a less toxic form of mercury
compared to methylmercury.
Although the Institute of Medicine already stated that there
is no concrete evidence that the MMR vaccine causes autism,
people are still skeptical. No one suspected thimerosal to be
toxic, seeing as it was found in such small doses in vaccines.
In the 1970’s it was known that large doses of mercury were
harmful. It was only in the late 1990’s that scientists suggested
that even relatively low exposure to organic mercury could be
dangerous to fetuses and young infants (Baker, 2008). The U.S.
Food and Drug Administration suggested removing thimerosal
from vaccines in 2001, because of the biological plausibility that
thimerosal may pose as a neurotoxic harm. However, trace
amounts of thimerosal are present in influenza vaccines which
infants and pregnant women may be exposed to. Six studies
were included, testing for a link between thimerosal-containing
vaccines and autism. The results of the studies suggested that
there is no connection between thimerosal and increased risk
of autism (Kalkbrenner et. al., 2014).

Conclusion
The causes of autism are still vague. Because it is characterized
as a spectrum disorder there can be many different variables
that can play a role in causing different levels of it. The theory that vaccinations cause autism has become a popular idea,
therefore much research has been done to make a correct conclusion. Until the causes of autism are confirmed research is
still being done to see what role vaccinations have on autism,
however the research that has been done until now has concluded that vaccinations do not have a link to ASD. Another
highly researched cause of autism is a genetic cause, be it a
genetic mutation or a number of other different genetic variables. In this paper the idea that different genetic mutations
that can cause autism has been discussed, and while some studies have brought optimistic results, further studies have to be
conducted. Other genetic factors that have been discussed are
the effect of maternal diabetes on the fetus, and parental age
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when the child was conceived. While further research is needed to confirm these factors, the studies that have been done
have given additional insight into what causes autism. Another
possible cause for ASD that was discussed was a mixture of
genetic and environmental factors that the child was exposed
to either as a fetus or as an infant. While some environmental
factors that have been tested had no correlation to ASD, other
environmental factors did show a correlation, although more
research is required.
Many studies are constantly being done, and researchers are
discovering more factors that might be a cause for ASD. The
closer they come to finding a cause, the closer they get to trying
to find a way to prevent autism from becoming more prevalent,
and maybe even closer to finding a possible cure for Autism
Spectrum Disorder.
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